Loading company…
Riskpilot
← Back to search
Sign in
Get full access
PharmaSphere Consulting ApS
APS
Active
CVR 36696222
Linde Alle 25
Engineering activities and related technical consultancy · NACE 7112
Est. 2015
1 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2025
DKK 2,5M
-6% vs 2024
EBITDA margin
16.6%
-54% vs 2024
Equity ratio
52.9%
Financial strength
Net profit 2025
DKK 322K
-53% vs 2024
EBITDA — year on year
DKK millions
1M
1M
1M
0M
0M
0M
2021
0M
0%
2022
0M
0%
2023
1M
+100%
2024
0M
-100%
2025
Key figures
Annual report 2025
Revenue
DKK 2,5M
-6%
EBITDA
DKK 412K
-54%
Net profit
DKK 322K
-53%
Total assets
DKK 881K
-36%
Equity
DKK 467K
-37%
Employees
1
—
Company information
Legal name
PharmaSphere Consulting ApS
CVR number
36696222
Legal form
Anpartsselskab
NACE code
7112 · Engineering activities and related technical consultancy
Founded
23. marts 2015
Share capital
DKK 50.000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Virksomheden tegnes af en direktør alene.
Company purpose
Selskabets formål er at sikre livsvigtig medicin til patienter ved konstruktivt at arbejde med mennesker og processer i medicinalbranchen
Contact
Address
Linde Alle 25
Phone
+4529738822
Email
st@psc.as
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Engineering activities and related technical consultancy
Companies in Ballerup
All Denmark companies
Revenue
DKK millions
0M
1M
2M
3M
3M
0M
2021
1M
2022
2M
2023
3M
2024
2M
2025
EBITDA
DKK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
1M
2024
0M
2025
Income statement
DKK thousands
Item
2021
2022
2023
2024
2025
Revenue
138
916
1.680
2.630
2.480
Staff expenses
-21
-571
-1.267
-1.742
-2.068
EBITDA
116
345
413
888
412
Depreciation & amort.
-0
-0
-0
-0
-0
EBIT
116
345
413
888
412
Net financials
-4
-4
-3
-4
1
Profit before tax
112
342
410
883
413
Tax
25
75
91
195
91
Net profit
88
266
320
688
322
Balance sheet
DKK thousands
Item
2021
2022
2023
2024
2025
Total assets
204
663
1.013
1.378
881
Equity
138
317
386
745
467
Long-term debt
0
0
0
0
0
Short-term debt
67
346
626
633
415
Total debt
67
346
626
633
415
Financial ratios
5-year trend
EBITDA margin
16.6%
This company
15.8%
Market median
+5% vs market
2021
2025
Equity ratio
52.9%
This company
38.2%
Market median
+38% vs market
2021
2025
Return on equity
68.9%
This company
18.4%
Market median
+274% vs market
2021
2025
Net profit margin
13.0%
This company
8.1%
Market median
+60% vs market
2021
2025
Asset turnover
2.81×
This company
1.12×
Market median
+151% vs market
2021
2025
Debt / equity
0.89×
This company
0.62×
Market median
+44% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
SG
Søren Graves Truelsen
Management
Management
2015
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
STruelsen-Holding ApS
Company
100%
100%
2015
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
STruelsen-Holding ApS
PharmaSphere Consulting ApS
(this company)
Board network connections
Board members of PharmaSphere Consulting ApS also hold positions in
0
other companies.
Person
Role here
Other companies
Søren Graves Truelsen
Management
0 companies